Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women who have gone through menopause (their periods have permanently stopped)
- Women between 40 and 65 years of age
Who may not be able to join:
- Women who have been in menopause for more than 10 years
- People with a thyroid condition or thyroid disorder
- People with high blood pressure
- People with a history of a psychiatric (mental health) condition
- People with a history of alcohol or drug misuse
- People with a history of neurological (brain or nervous system) conditions that affected memory or thinking
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Herman Depypere, MD, University Hospital, Ghent
Phone: 0032 9 332 78 17
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Degradation products of the Amyloid metabolism in blood; Degradation products of the Amyloid metabolism in blood; Degradation products of the Amyloid metabolism in blood; Degradation products of the Amyloid metabolism in blood; Degradation products of the Amyloid metabolism in blood; Degradation products of the Amyloid metabolism in blood; APOE-genotyping in blood; identify BACE1 in blood
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.